Ph1-positive, bcr-negative acute leukemias: clustering of breakpoints on chromosome 22 in the 3' end of the BCR gene first intron.

Abstract:

:About 50% of the Philadelphia-positive acute leukemias undergo molecular rearrangements outside the now classical bcr sequence (or M-BCR-1) rearranged in chronic myeloid leukemia (CML). Most of the breakpoints on chromosome 22 have been shown to be clustered in a 10.8-kb region of the first intron of the BCR gene (called bcr2 or m-BCR-1). In this report we examined two cases of Ph1 acute lymphoblastic leukemia in adult patients that exhibited breakpoints in a 5-kb segment of the BCR gene first intron, 16 kb upstream of the previously described cluster, suggesting the possibility of a second minor breakpoint cluster. In addition, the breakpoints on chromosome 9 were located in a region just 5' of the c-abl exon la.

journal_name

Blood

journal_title

Blood

authors

Chen SJ,Chen Z,Hillion J,Grausz D,Loiseau P,Flandrin G,Berger R

subject

Has Abstract

pub_date

1989-04-01 00:00:00

pages

1312-5

issue

5

eissn

0006-4971

issn

1528-0020

journal_volume

73

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs.

    abstract::Hematopoietic stem cell (HSC)-based gene therapy holds promise for the cure of many diseases. The field is now moving toward the use of lentiviral vectors (LVs) as evidenced by 4 successful clinical trials. These trials used vesicular-stomatitis-virus-G protein (VSV-G)-LVs at high doses combined with strong cytokine-c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-02-558163

    authors: Girard-Gagnepain A,Amirache F,Costa C,Lévy C,Frecha C,Fusil F,Nègre D,Lavillette D,Cosset FL,Verhoeyen E

    更新日期:2014-08-21 00:00:00

  • Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment.

    abstract::The events that regulate engraftment and long-term repopulating ability of hematopoietic stem cells (HSCs) after transplantation are not well defined. We report for the first time that major histocompatibility complex (MHC) class I K plays a critical role in HSC engraftment via interaction with recipient natural kille...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3910

    authors: Huang Y,Rezzoug F,Chilton PM,Grimes HL,Cramer DE,Ildstad ST

    更新日期:2004-08-01 00:00:00

  • Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.

    abstract::The course and treatment of a life-threatening hemorrhagic episode in a patient with hemophilia A whose plasma contained a high concentration of an inhibitor of factor VIII activity is presented. The inhibitor of factor VIII was localized to the most anodal fractions of immunoglobulin G on electrophoresis, and was thu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sonoda T,Solomon A,Krauss S,Cruz P,Jones FS,Levin J

    更新日期:1976-06-01 00:00:00

  • Chemotactic factor enhancement of superoxide release from fluoride and phorbol myristate acetate stimulated neutrophils.

    abstract::Human neutrophils exposed to chemotactic concentrations of zymosan-activated serum (ZAS) and a formylated chemotactic peptide (FMLP, 10(-7)--10(-9) M) were markedly enhanced in their ability to generate superoxide (O2-) upon stimulation with either sodium fluoride or phorbol myristate acetate (PMA). For both fluoride ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: English D,Roloff JS,Lukens JN

    更新日期:1981-07-01 00:00:00

  • Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

    abstract::Natural killer (NK) cells can alter the outcome of hematopoietic cell transplantation (HCT) if donor alloreactivity targets the recipient. Since most NK cells express inhibitory killer-immunoglobulin receptors (KIRs), we hypothesized that the susceptibility of recipient cells to donor NK cell-mediated lysis is genetic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-065383

    authors: Miller JS,Cooley S,Parham P,Farag SS,Verneris MR,McQueen KL,Guethlein LA,Trachtenberg EA,Haagenson M,Horowitz MM,Klein JP,Weisdorf DJ

    更新日期:2007-06-01 00:00:00

  • G-CSF-treated granulocytes inhibit acute graft-versus-host disease.

    abstract::It has been shown that in vivo and in vitro treatment with G-CSF induces the generation of low-density granulocytes (LDGs), which copurify with PBMCs and inhibit IFN-gamma production by human T cells. These results prompted us to postulate an immunomodulatory role for LDGs in acute graft-versus-host disease (aGVHD). H...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-08-3239

    authors: Vasconcelos ZF,Dos Santos BM,Farache J,Palmeira TS,Areal RB,Cunha JM,Barcinski MA,Bonomo A

    更新日期:2006-03-01 00:00:00

  • Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

    abstract::Wilms' tumor 1 (WT1) is constantly expressed in leukemic cells of acute leukemia and myelodysplastic syndrome (MDS). A T-cell receptor (TCR) that specifically reacts with WT1 peptide in the context of HLA-A*24:02 has been identified. We conducted a first-in-human trial of TCR-gene transduced T-cell (TCR-T-cell) transf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-791202

    authors: Tawara I,Kageyama S,Miyahara Y,Fujiwara H,Nishida T,Akatsuka Y,Ikeda H,Tanimoto K,Terakura S,Murata M,Inaguma Y,Masuya M,Inoue N,Kidokoro T,Okamoto S,Tomura D,Chono H,Nukaya I,Mineno J,Naoe T,Emi N,Yasukawa M,

    更新日期:2017-11-02 00:00:00

  • Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells.

    abstract::STI571 induces sustained hematologic remission in patients with chronic myeloid leukemia (CML) in chronic phase. However, in advanced phases, especially blast crisis, the leukemia usually becomes resistant within months. It has been investigated whether resistance to STI571 is stable and immutable or whether it can be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.13.3864

    authors: Tipping AJ,Mahon FX,Lagarde V,Goldman JM,Melo JV

    更新日期:2001-12-15 00:00:00

  • 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

    abstract::In an attempt to improve outcomes for patients with acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT), we conducted a phase 1/2 study in which targeted irradiation delivered by 131I-anti-CD45 antibody was combined with targeted busulfan (BU; area-under-curve, 600-900 ng/mL) and cyc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2317

    authors: Pagel JM,Appelbaum FR,Eary JF,Rajendran J,Fisher DR,Gooley T,Ruffner K,Nemecek E,Sickle E,Durack L,Carreras J,Horowitz MM,Press OW,Gopal AK,Martin PJ,Bernstein ID,Matthews DC

    更新日期:2006-03-01 00:00:00

  • Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro.

    abstract::Deferoxamine (DF) has antimalarial activity that can be demonstrated in vitro and in vivo. This study is designed to examine the speed of onset and stage dependency of growth inhibition by DF and to determine whether its antimalarial activity is cytostatic or cytocidal. Growth inhibition was assessed by suppression of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Whitehead S,Peto TE

    更新日期:1990-09-15 00:00:00

  • Cervical carotid artery disease in sickle cell anemia: clinical and radiological features.

    abstract::Cervical internal carotid artery (cICA) occlusion is a recognized cause of acute ischemic stroke (AIS) in sickle cell disease (SCD), but the associated clinical and radiologic features are not well described. We reviewed data on cervical magnetic resonance angiography (cMRA) performed prospectively in 67 patients (55 ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-03-337915

    authors: Telfer PT,Evanson J,Butler P,Hemmaway C,Abdulla C,Gadong N,Whitmarsh S,Kaya B,Kirkham FJ

    更新日期:2011-12-01 00:00:00

  • Purification and partial amino acid sequence of human platelet membrane glycoproteins IIb and IIIa.

    abstract::The glycoprotein (GP) IIb-IIIa complex was isolated from human platelet membranes by immunoaffinity chromatography using a monoclonal antibody specific for GP IIb-IIIa. GP IIb and IIIa were further separated in the presence of sodium dodecyl sulfate (SDS) by gel filtration high-performance liquid chromatography (HPLC)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hiraiwa A,Matsukage A,Shiku H,Takahashi T,Naito K,Yamada K

    更新日期:1987-02-01 00:00:00

  • Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.

    abstract::CXC ligand 12 (CXCL12; also known as stromal cell-derived factor 1alpha/SDF-1alpha) chemoattracts hematopoietic stem and progenitor cells (HSCs/HPCs) and is thought to play a crucial role in the mobilization of HSCs/HPCs from the bone marrow. CD26 (dipeptidylpeptidase IV [DPPIV]) is a membrane-bound extracellular pept...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3893

    authors: Christopherson KW 2nd,Cooper S,Broxmeyer HE

    更新日期:2003-06-15 00:00:00

  • Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

    abstract::This 2-part, double-blind, placebo-controlled study was conducted to determine the safety and efficacy of etoricoxib, a COX-2 selective inhibitor, for the treatment of hemophilic arthropathy. In part 1 (6 weeks), 102 patients (> or = 12 years old) with hemophilic arthropathy were randomized to receive 90 mg etoricoxib...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2004-09-3501

    authors: Tsoukas C,Eyster ME,Shingo S,Mukhopadhyay S,Giallella KM,Curtis SP,Reicin AS,Melian A

    更新日期:2006-03-01 00:00:00

  • Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

    abstract::A polymorphic variant of the phosphatase PTPN22 has been associated with increased risk for multiple autoimmune diseases. The risk allele is thought to function by diminishing antigen-receptor signals responsible for negative selection of autoreactive lymphocytes. We now show that PTPN22 is markedly overexpressed in c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403162

    authors: Negro R,Gobessi S,Longo PG,He Y,Zhang ZY,Laurenti L,Efremov DG

    更新日期:2012-06-28 00:00:00

  • The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.

    abstract::Anaplastic large cell lymphoma represents a subset of neoplasms caused by translocations that juxtapose the anaplastic lymphoma kinase (ALK) to dimerization partners. The constitutive activation of ALK fusion proteins leads to cellular transformation through a complex signaling network. To elucidate the ALK pathways s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161018

    authors: Boccalatte FE,Voena C,Riganti C,Bosia A,D'Amico L,Riera L,Cheng M,Ruggeri B,Jensen ON,Goss VL,Lee K,Nardone J,Rush J,Polakiewicz RD,Comb MJ,Chiarle R,Inghirami G

    更新日期:2009-03-19 00:00:00

  • Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

    abstract::The receptor for hyaluronic acid-mediated motility (RHAMM/CD168) has been described as a leukemia-associated antigen. To define T-cell epitopes of RHAMM/CD168 toward specific immunotherapies for acute myeloid leukemia (AML), 10 potential HLA-A2-binding RHAMM/CD168 peptides (R1 to R10) were synthesized based on compute...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4787

    authors: Greiner J,Li L,Ringhoffer M,Barth TF,Giannopoulos K,Guillaume P,Ritter G,Wiesneth M,Döhner H,Schmitt M

    更新日期:2005-08-01 00:00:00

  • Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

    abstract::Hodgkin- and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin lymphomas (cHL) of 40 patients comprising 8 lymphocyte-rich (cHL-LR), 16 nodular sclerosis (cHL-NS), 15 mixed-cellularity (cHL-MC), and 2 lymphocyte-depletion (cHL-LD) subtypes were analyzed by comparative genomic hybridization for recurr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1381

    authors: Joos S,Menz CK,Wrobel G,Siebert R,Gesk S,Ohl S,Mechtersheimer G,Trümper L,Möller P,Lichter P,Barth TF

    更新日期:2002-02-15 00:00:00

  • Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.

    abstract::We made a disease-specific comparison of unrelated cord blood (CB) recipients and human leukocyte antigen allele-matched unrelated bone marrow (BM) recipients among 484 patients with acute myeloid leukemia (AML; 173 CB and 311 BM) and 336 patients with acute lymphoblastic leukemia (ALL; 114 CB and 222 BM) who received...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2008-03-147041

    authors: Atsuta Y,Suzuki R,Nagamura-Inoue T,Taniguchi S,Takahashi S,Kai S,Sakamaki H,Kouzai Y,Kasai M,Fukuda T,Azuma H,Takanashi M,Okamoto S,Tsuchida M,Kawa K,Morishima Y,Kodera Y,Kato S,Japan Cord Blood Bank Network.

    更新日期:2009-02-19 00:00:00

  • Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that accounts for ∼20% of ALL cases. Intensive chemotherapy regimens result in cure rates >85% in children and <50% in adults, warranting a search of novel therapeutic strategies. Although immune-based therapies have tremendously improved the trea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003801

    authors: Tran Quang C,Zaniboni B,Humeau R,Lengliné E,Dourthe ME,Ganesan R,Singh S,Scheer JM,Asnafi V,Ghysdael J

    更新日期:2020-09-10 00:00:00

  • Thrombopoietin therapy increases platelet yields in healthy platelet donors.

    abstract::The recombinant thrombopoietins have been shown to be effective stimulators of platelet production in cancer patients. It was therefore of interest to determine if one of these, pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF), could be used to increase platelet counts and conseque...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood.v98.5.1339

    authors: Kuter DJ,Goodnough LT,Romo J,DiPersio J,Peterson R,Tomita D,Sheridan W,McCullough J

    更新日期:2001-09-01 00:00:00

  • Posttranslational processing of a human myeloid lysosomal protein, myeloperoxidase.

    abstract::Myeloperoxidase (MPO) is a lysosomal enzyme present in the azurophilic granules of human neutrophils and monocytes and is important for optimal oxygen-dependent killing of microorganisms. The native molecule is a heterodimer composed of a pair of heavy-light protomers, each containing a 59-kDa and 13.5-kDa subunit. Th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nauseef WM

    更新日期:1987-10-01 00:00:00

  • Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

    abstract::Acute graft-versus-host disease (GVHD) is the primary limitation of allogeneic hematopoietic cell transplantation, and once it develops, there are no reliable diagnostic tests to predict treatment outcomes. We hypothesized that 6 previously validated diagnostic biomarkers of GVHD (IL-2 receptor-α; tumor necrosis facto...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403063

    authors: Levine JE,Logan BR,Wu J,Alousi AM,Bolaños-Meade J,Ferrara JL,Ho VT,Weisdorf DJ,Paczesny S

    更新日期:2012-04-19 00:00:00

  • Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.

    abstract::The association of thrombosis and gestational morbidity with antiphospholipid antibodies is termed antiphospholipid syndrome (APS). Annexin 2 (A2) is a profibrinolytic endothelial cell surface receptor that binds plasminogen, its tissue activator (tPA), and beta(2)-glycoprotein I (beta2GPI), the main antigen for antip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2636

    authors: Cesarman-Maus G,Ríos-Luna NP,Deora AB,Huang B,Villa R,Cravioto Mdel C,Alarcón-Segovia D,Sánchez-Guerrero J,Hajjar KA

    更新日期:2006-06-01 00:00:00

  • Alloimmunization following prophylactic granulocyte transfusion.

    abstract::Nineteen noninfected adults receiving initial induction chemotherapy for acute nonlymphocytic leukemia (ANLL) were randomized to receive either prophylactic granulocyte transfusion or platelet transfusion alone on an alternate-day schedule. An average of 11 granulocyte transfusions (range 3--19) were administered/pati...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Schiffer CA,Aisner J,Daly PA,Schimpff SC,Wiernik PH

    更新日期:1979-10-01 00:00:00

  • Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.

    abstract::B-cell chronic lymphocytic leukemia (CLL) consists of 2 prognostic entities where cases with mutated immunoglobulin V(H) genes have better outcome than unmutated cases. V(H)-mutated CLLs display longer telomeres compared with unmutated cases and telomere length has been indicated to predict outcome, although the progn...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4394

    authors: Grabowski P,Hultdin M,Karlsson K,Tobin G,Aleskog A,Thunberg U,Laurell A,Sundström C,Rosenquist R,Roos G

    更新日期:2005-06-15 00:00:00

  • Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors.

    abstract::Merkel cell polyomavirus (MCPyV), a DNA tumor virus, has been found to be associated with Merkel cell carcinoma and chronic lymphocytic leukemia. MCPyV sequences have also been detected in various normal tissues in tumor-affected patients. Immunologic studies have detected MCPyV antibodies in as many as 80% of healthy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-310557

    authors: Pancaldi C,Corazzari V,Maniero S,Mazzoni E,Comar M,Martini F,Tognon M

    更新日期:2011-06-30 00:00:00

  • Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

    abstract::Epigenetic events that are essential drivers of lymphocyte transformation remain incompletely characterized. We used models of Epstein-Barr virus (EBV)-induced B-cell transformation to document the relevance of protein arginine methyltransferase 5 (PRMT5) to regulation of epigenetic-repressive marks during lymphomagen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-12-619783

    authors: Alinari L,Mahasenan KV,Yan F,Karkhanis V,Chung JH,Smith EM,Quinion C,Smith PL,Kim L,Patton JT,Lapalombella R,Yu B,Wu Y,Roy S,De Leo A,Pileri S,Agostinelli C,Ayers L,Bradner JE,Chen-Kiang S,Elemento O,Motiwala T

    更新日期:2015-04-16 00:00:00

  • CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.

    abstract::Intravenous infusion of autologous chronic lymphocytic leukemia (CLL) cells transduced with an adenovirus encoding CD40-ligand (CD154) caused rapid reductions in leukemia-cell counts and lymphnode size. We hypothesized that CD40-ligation via CD154 sensitized CLL cells to death-receptor-mediated apoptosis. We found tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-04-017749

    authors: Dicker F,Kater AP,Prada CE,Fukuda T,Castro JE,Sun G,Wang JY,Kipps TJ

    更新日期:2006-11-15 00:00:00

  • A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.

    abstract::We show that lentiviral delivery of human gamma-globin gene under beta-globin regulatory control elements in hematopoietic stem cells (HSCs) results in sufficient postnatal fetal hemoglobin (HbF) expression to correct sickle cell anemia (SCA) in the Berkeley "humanized" sickle mouse. Upon de-escalating the amount of t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-201863

    authors: Perumbeti A,Higashimoto T,Urbinati F,Franco R,Meiselman HJ,Witte D,Malik P

    更新日期:2009-08-06 00:00:00